10x Genomics Inc - Ordinary Shares - Class A


Market Cap$3.82B

Compare 10x Genomics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
10x Genomics Inc - Ordinary Shares - Class A10x Genomics Inc - Ordinary Shares - Class A-150%-34%6.9-
marketMarket Avg58.91.26%30%-1
HealthcareHealthcare Avg64.71.29%15%7.30.9

Target Price by Analysts

30.2% upside10x Genomics Target Price DetailsTarget Price

Current Fair Value

21.7% upside

Undervalued by 21.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.82 Billion
Enterprise Value$3.43 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-2.18
Outstanding Shares105,109,711
Avg 30 Day Volume1,294,649


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-14.98
Price to Sales6.91
Price to Book Ratio4.94
Enterprise Value to Revenue5.55
Enterprise Value to EBIT-16.8
Enterprise Value to Net Income-14
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About 10x Genomics Inc

CEO: Serge Saxonov